Alitretinoin for the treatment of severe chronic hand eczema

NICE technology appraisals [TA177] Published date:

Alitretinoin is recommended as a possible treatment for people with severe chronic hand eczema if:

  • their eczema has not improved with treatments called potent topical corticosteroids and
  • standard assessments show that their eczema is severe and is affecting their quality of life.

Alitretinoin treatment should be stopped:

  • as soon as the eczema has clearly improved or
  • if the eczema remains severe after 12 weeks or
  • if the eczema has not clearly improved after 24 weeks.

Treatment with alitretinoin should be started and monitored only by doctors who:

  • are skin specialists (dermatologists) or
  • have experience in both treating people with severe chronic hand eczema and using drugs like alitretinoin.

When assessing how a person’s eczema affects their quality of life, healthcare professionals should take into account any disabilities or difficulties in communicating which might mean that the standard assessments do not provide accurate information.

Get involved